Live
- Poonam Prabhakar challenges Bandi Sanjay to tell what BJP has done in past decade
- 27pc spike in anti-vaccine posts on X after Covid jabs were available: Study
- Elon Musk visits China, likely to promote Tesla's driverless tech: Report
- Sri Lanka signals shift in interest as Indian firm to jointly manage China-built airport close to strategic Hambantota port
- Iran unveils new 'kamikaze' drone
- Bangladesh faces longest-ever heatwave
- UP: Samajwadi Party faces its biggest challenge in third phase polls
- UK PM Sunak again refuses to rule out July general election
- Russia, Ukraine launch drone strikes
- ‘Lovely experienced personal pain over last 2 to 3 months', says Congress leader Sandeep Dikshit
New blood test to detect silent, lethal pancreatic cancer
Representational image
Researchers have developed a novel blood test that could lead to the first early detection for pancreatic cancer.
Sydney: Researchers have developed a novel blood test that could lead to the first early detection for pancreatic cancer.
Pancreatic cancer has a poor survival rates marred by a lack of distinct symptoms and screening tools needed to detect the disease in its initial stages.
The team from Walter and Eliza Hall Institute of Medical Research (WEHI) in Australia hopes that the test will, for the first time, accurately identify patients with early stages of pancreatic cancer – a crucial step towards improving survival rates and quality of life for patients.
“There are no early detection biomarkers for pancreatic cancer and this needs to urgently change,” said Dr Belinda Lee, a consultant medical oncologist at WEHI.
The team identified 13 proteins that could distinguish between the early and late stages of pancreatic ductal adenocarcinoma (PDAC) -- the most common type of pancreatic cancer that’s fast-becoming the cancer of our generation.
“We hope to validate these proteins and show that they can be used to reliably screen for early pancreatic cancer," Lee said.
“This would allow us to create the first diagnostic test to identify patients who have early stages of pancreatic cancer -- something that unfortunately does not exist at the moment," she added.
